Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

If you’re older, you may get a more severe infection than a younger person would, especially if you have an underlying chronic condition.” While vaccines don’t prevent older adults from getting ...

The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

A vaccination programme introduced to protect babies and older adults against a dangerous respiratory disease has cut ...

The NHS has begun inviting older people in Oxfordshire to receive their respiratory syncytial virus (RSV) vaccine.

NHS England appeals for 1.3 million eligible people to come forward for a new jab against respiratory syncytial virus (RSV) ...

Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...

In adults aged 50 years and older, coadministration of respiratory syncytial virus vaccine mRNA-1345 plus seasonal influenza or COVID-19 vaccines was safe and noninferior to individual vaccine ...

The NHS rolled out the first ever routine vaccination programme this winter, with estimates suggesting it could prevent up to ...

Respiratory syncytial virus (RSV) is known to cause considerable respiratory infection-related morbidity and mortality worldwide.1,2 Estimates published in 2022 from the UK highlight the ...

RSV infections are common but while most people are fine 29,000 children are admitted to hospital in the UK every year ...